Papaverine prior to catheter balloon insertion for labor induction: a randomized controlled trial

IF 3.8 2区 医学 Q1 OBSTETRICS & GYNECOLOGY
Raneen Abu Shqara MD , Yara Nakhleh Francis MD , Gabriela Goldinfeld MD , Yousef Haddad MD , Inshirah Sgayer MD , Miri Lavinsky BA , Lior Lowenstein MD , Maya Frank Wolf MD
{"title":"Papaverine prior to catheter balloon insertion for labor induction: a randomized controlled trial","authors":"Raneen Abu Shqara MD ,&nbsp;Yara Nakhleh Francis MD ,&nbsp;Gabriela Goldinfeld MD ,&nbsp;Yousef Haddad MD ,&nbsp;Inshirah Sgayer MD ,&nbsp;Miri Lavinsky BA ,&nbsp;Lior Lowenstein MD ,&nbsp;Maya Frank Wolf MD","doi":"10.1016/j.ajogmf.2024.101388","DOIUrl":null,"url":null,"abstract":"<div><h3>BACKGROUND</h3><p>Catheter balloon insertion is a common method for cervical ripening and labor induction. Papaverine and its derivatives are musculotropic antispasmodic drugs that directly induce smooth muscle relaxation. Used during childbirth, these drugs have been suggested to shorten the duration of labor.</p></div><div><h3>OBJECTIVE</h3><p>This study aimed to evaluate the effect of administering papaverine before catheter balloon insertion on changes in Bishop scores and on the labor induction–to–delivery interval.</p></div><div><h3>STUDY DESIGN</h3><p>This randomized, double-blinded, placebo-controlled trial was conducted in a single tertiary university-affiliated hospital. Participants were admitted at term for labor induction with an initial Bishop score of ≤6. Participants were randomized to receive 80 mg intravenous papaverine or 0.9% normal saline solution within 30 minutes of Foley catheter balloon insertion. The co-primary outcomes were the difference in Bishop score from before catheter balloon insertion to after removal and the labor induction–to–delivery interval. The secondary outcomes included maternal pain and satisfaction scores, delivery within 24 hours, and neonatal outcomes. Both intention-to-treat and per-protocol analyses were performed.</p></div><div><h3>RESULTS</h3><p>Overall, 110 women were enrolled. In the intention-to-treat analysis, the median difference in Bishop score was greater in the papaverine group than in the placebo group (5 [interquartile range, 1-11] vs 4 [interquartile range, 0-7], respectively; <em>P</em>=.025), and the median catheter balloon insertion–to–delivery interval was shorter in the papaverine group than in the placebo group (21 hours [interquartile range, 6–95] vs 26 hours [interquartile range, 3–108], respectively; <em>P</em>=.031). A higher proportion of women delivered within 24-hours in the papaverine group than in the placebo group (65.5% vs 41.8%, respectively; <em>P</em>=.012). Pain and satisfaction scores, delivery, and neonatal outcomes were similar between the groups. Similar results were found in the per-protocol analysis.</p></div><div><h3>CONCLUSION</h3><p>Papaverine administration before Foley catheter balloon insertion for cervical ripening resulted in improved Bishop scores and shorter catheter balloon insertion–to–delivery intervals.</p></div>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Obstetrics & Gynecology Mfm","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589933324001149","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND

Catheter balloon insertion is a common method for cervical ripening and labor induction. Papaverine and its derivatives are musculotropic antispasmodic drugs that directly induce smooth muscle relaxation. Used during childbirth, these drugs have been suggested to shorten the duration of labor.

OBJECTIVE

This study aimed to evaluate the effect of administering papaverine before catheter balloon insertion on changes in Bishop scores and on the labor induction–to–delivery interval.

STUDY DESIGN

This randomized, double-blinded, placebo-controlled trial was conducted in a single tertiary university-affiliated hospital. Participants were admitted at term for labor induction with an initial Bishop score of ≤6. Participants were randomized to receive 80 mg intravenous papaverine or 0.9% normal saline solution within 30 minutes of Foley catheter balloon insertion. The co-primary outcomes were the difference in Bishop score from before catheter balloon insertion to after removal and the labor induction–to–delivery interval. The secondary outcomes included maternal pain and satisfaction scores, delivery within 24 hours, and neonatal outcomes. Both intention-to-treat and per-protocol analyses were performed.

RESULTS

Overall, 110 women were enrolled. In the intention-to-treat analysis, the median difference in Bishop score was greater in the papaverine group than in the placebo group (5 [interquartile range, 1-11] vs 4 [interquartile range, 0-7], respectively; P=.025), and the median catheter balloon insertion–to–delivery interval was shorter in the papaverine group than in the placebo group (21 hours [interquartile range, 6–95] vs 26 hours [interquartile range, 3–108], respectively; P=.031). A higher proportion of women delivered within 24-hours in the papaverine group than in the placebo group (65.5% vs 41.8%, respectively; P=.012). Pain and satisfaction scores, delivery, and neonatal outcomes were similar between the groups. Similar results were found in the per-protocol analysis.

CONCLUSION

Papaverine administration before Foley catheter balloon insertion for cervical ripening resulted in improved Bishop scores and shorter catheter balloon insertion–to–delivery intervals.

导管球囊插入引产前使用帕帕维林:随机对照试验。
背景介绍导管球囊植入是一种宫颈成熟的引产方法。木蝴蝶碱及其衍生物是一种肌肉解痉药,可直接诱导平滑肌松弛。在分娩过程中使用这些药物可缩短产程:我们的目的是评估在插入导尿管球囊前使用帕帕维林对 Bishop 评分变化和引产至分娩间隔时间的影响:这项随机双盲安慰剂对照试验在一家大学附属三级医院进行。参试者在临产时入院接受引产,初始毕晓普评分≤6。在插入 Foley 导管球囊后 30 分钟内,参与者被随机分配接受 80 毫克或 0.9% 生理盐水静脉注射。共同主要结果是插入导管气囊前与拔出导管气囊后的 Bishop 评分差异,以及从引产到分娩的时间间隔。次要结果包括产妇疼痛和满意度评分、24 小时内分娩情况和新生儿结局。结果:结果:共有 110 名产妇报名参加。在意向治疗分析中,与安慰剂组(55 人)相比,木瓜碱组(55 人)的 Bishop 评分中位数(范围)差异更大:7 分(范围,4-11 分)对 6 分(1-11 分),P=0.023;导管插入到分娩的中位数范围间隔更短:21(6-95)小时对 26(3-108)小时,P=0.031。与安慰剂组相比,木瓜碱组产妇在24小时内分娩的比例更高:65.5%对41.8%,P=0.012。两组的疼痛和满意度评分、分娩和新生儿结局相似。在按方案分析中也发现了类似的结果:结论:为宫颈成熟术插入 Foley 导管前使用帕帕维林可提高 Bishop 评分,缩短导管到分娩的时间间隔。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.40
自引率
3.20%
发文量
254
审稿时长
40 days
期刊介绍: The American Journal of Obstetrics and Gynecology (AJOG) is a highly esteemed publication with two companion titles. One of these is the American Journal of Obstetrics and Gynecology Maternal-Fetal Medicine (AJOG MFM), which is dedicated to the latest research in the field of maternal-fetal medicine, specifically concerning high-risk pregnancies. The journal encompasses a wide range of topics, including: Maternal Complications: It addresses significant studies that have the potential to change clinical practice regarding complications faced by pregnant women. Fetal Complications: The journal covers prenatal diagnosis, ultrasound, and genetic issues related to the fetus, providing insights into the management and care of fetal health. Prenatal Care: It discusses the best practices in prenatal care to ensure the health and well-being of both the mother and the unborn child. Intrapartum Care: It provides guidance on the care provided during the childbirth process, which is critical for the safety of both mother and baby. Postpartum Issues: The journal also tackles issues that arise after childbirth, focusing on the postpartum period and its implications for maternal health. AJOG MFM serves as a reliable forum for peer-reviewed research, with a preference for randomized trials and meta-analyses. The goal is to equip researchers and clinicians with the most current information and evidence-based strategies to effectively manage high-risk pregnancies and to provide the best possible care for mothers and their unborn children.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信